Range
- - -
Vol / Avg.
-/79K
Div / Yield
-
52 Wk
2.55 - 6.42
Mkt Cap
23.3M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.37
Shares
8.1M
Outstanding
8.1M
Total Float
-
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; NM-088 for the treatment of glaucoma; and IntegraSyn.

Related Companies

TickerCompanyChg %Mkt Cap
INMInMed Pharmaceuticals1.4%23.3M

InMed Pharmaceuticals Frequently Asked Questions

Q

How do I buy InMed Pharmaceuticals (INM) stock?

A

You can purchase shares of InMed Pharmaceuticals (NASDAQ: INM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are InMed Pharmaceuticals's (INM) competitors?

A

There are no as such competitors for InMed Pharmaceuticals.

Q

What is the target price for InMed Pharmaceuticals (INM) stock?

A

There is no analysis for InMed Pharmaceuticals

Q

Current Stock Price for InMed Pharmaceuticals (INM)?

A

The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $2.89 last updated Mon Jun 14 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does InMed Pharmaceuticals (INM) pay a dividend?

A

There are no upcoming dividends for InMed Pharmaceuticals.

Q

When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?

A

InMed Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is InMed Pharmaceuticals (INM) going to split?

A

There is no upcoming split for InMed Pharmaceuticals.

Q

What sector and industry does InMed Pharmaceuticals (INM) operate in?

A

InMed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.